Drug Profile
H5N1 avian influenza virus vaccine - Vaxart
Alternative Names: Avian influenza vaccine - Vaxart; Bird flu vaccine - Vaxart; ND1; ND1.1Latest Information Update: 01 Nov 2023
Price :
$50
*
At a glance
- Originator Vaxart
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(Prevention) in USA (PO, Capsule)
- 09 Feb 2016 Vaxart plans a phase II trial for Influenza-A virus H5N1 subtype (Prevention)
- 01 Nov 2013 Vaxart completes a phase I trial in Influenza virus H5N1 subtype (intestinal delivery) in USA (NCT01698060)